GEMCITABINE INTRAVESICAL

GEMCITABINE INTRAVESICAL was reported 484 times

GEMCITABINE INTRAVESICAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FLUORESCENT IN SITU HYBRIDISATION POSITIVE 1 0.1000
1 CULTURE URINE NEGATIVE 1 0.0909
2 LOWER URINARY TRACT SYMPTOMS 18 0.0497
3 SCROTAL IRRITATION 1 0.0227
4 REDUCED BLADDER CAPACITY 2 0.0225
5 CYSTOSCOPY ABNORMAL 1 0.0217
6 DIPHTHERIA 1 0.0213
7 BLADDER IRRITATION 12 0.0187
8 CATHETER SITE SCAR 1 0.0167
9 BLADDER SPASM 31 0.0165
10 BLADDER NECK OBSTRUCTION 2 0.0146
11 MUCOSAL EXFOLIATION 1 0.0130
12 BLADDER PAPILLOMA 1 0.0128
13 BLADDER STENOSIS 1 0.0122
14 TRANSURETHRAL BLADDER RESECTION 1 0.0122
15 BLADDER PAIN 38 0.0120
16 TRANSITIONAL CELL CANCER OF THE RENAL PELVIS AND URETER 1 0.0106
17 ANAL RASH 1 0.0104
18 URETHRAL PAIN 6 0.0102
19 IMAGING PROCEDURE ABNORMAL 1 0.0100
20 URINARY TRACT PAIN 5 0.0099
21 BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT 1 0.0098
22 CHEMICAL BURN OF GENITALIA 1 0.0082
23 CYSTITIS NONINFECTIVE 10 0.0074
24 CYSTOSCOPY 1 0.0063
25 CONTRACTED BLADDER 1 0.0062
26 CARCINOMA IN SITU 1 0.0060
27 BLADDER DISCOMFORT 7 0.0056
28 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 2 0.0055
29 URETHRAL CANCER 1 0.0046
30 MICTURITION URGENCY 52 0.0045
31 URETHRAL STENOSIS 3 0.0044
32 HYPERTONIC BLADDER 11 0.0038
33 URETERITIS 1 0.0036
34 PROSTATIC HAEMORRHAGE 1 0.0031
35 BLADDER INJURY 1 0.0031
36 PENILE OEDEMA 1 0.0031
37 DYSURIA 94 0.0026
38 PROSTATIC PAIN 1 0.0025
39 HAEMORRHAGE URINARY TRACT 6 0.0024
40 POLLAKIURIA 96 0.0023
41 URGE INCONTINENCE 2 0.0023
42 PENILE PAIN 7 0.0023
43 URINARY TRACT DISCOMFORT 1 0.0022
44 URETHRAL DISORDER 1 0.0021
45 BLADDER MASS 1 0.0020
46 BLADDER NEOPLASM 3 0.0018
47 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS PERFORMED IN ERROR 1 0.0016
48 CATHETER SITE HAEMORRHAGE 4 0.0016
49 GENITAL SWELLING 1 0.0014
50 BLADDER TRANSITIONAL CELL CARCINOMA 2 0.0014
51 EXPOSURE TO COMMUNICABLE DISEASE 1 0.0013
52 EXCESSIVE GRANULATION TISSUE 1 0.0012
53 GENITAL BURNING SENSATION 1 0.0012
54 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
55 SCROTAL SWELLING 1 0.0011
56 BLOOD URINE 1 0.0010
57 PROSTATOMEGALY 4 0.0010
58 BLADDER CANCER RECURRENT 1 0.0010
59 PROCTALGIA 6 0.0009
60 ORCHITIS 1 0.0009
61 BLADDER DILATATION 1 0.0009
62 URINARY TRACT DISORDER 4 0.0009
63 BLOODY DISCHARGE 1 0.0009
64 BLADDER DISORDER 8 0.0008
65 HAEMATURIA 27 0.0008
66 CATHETER SITE PAIN 2 0.0008
67 OFF LABEL USE OF DEVICE 1 0.0007
68 URETERIC OBSTRUCTION 1 0.0007
69 CALCULUS BLADDER 1 0.0007
70 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
71 GENITAL RASH 1 0.0007
72 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
73 NOCTURIA 7 0.0006
74 INCONTINENCE 6 0.0006
75 DEVICE PLACEMENT ISSUE 2 0.0006
76 PROCEDURAL HAEMORRHAGE 2 0.0005
77 COMPLICATION OF DEVICE INSERTION 10 0.0005
78 DEVICE DEPOSIT ISSUE 1 0.0005
79 URINARY BLADDER HAEMORRHAGE 1 0.0005
80 DEVICE CONNECTION ISSUE 1 0.0005
81 URINARY INCONTINENCE 14 0.0005
82 CALCINOSIS 1 0.0004
83 URINE ABNORMALITY 2 0.0004
84 URINARY TRACT OBSTRUCTION 1 0.0004
85 URINE FLOW DECREASED 1 0.0004
86 HAEMATOLOGICAL INFECTION 1 0.0004
87 PRODUCT SOLUBILITY ABNORMAL 2 0.0004
88 PYELONEPHRITIS 3 0.0003
89 DEVICE DISLOCATION 15 0.0003
90 URINE ANALYSIS ABNORMAL 1 0.0003
91 PROSTATITIS 1 0.0003
92 MEDICAL DEVICE DISCOMFORT 1 0.0003
93 LYME DISEASE 1 0.0003
94 NEOPLASM RECURRENCE 1 0.0003
95 HEPATIC CYST 1 0.0003
96 PRODUCT CONTAMINATION 1 0.0003
97 DEVICE KINK 1 0.0003
98 HYDRONEPHROSIS 2 0.0003
99 URINARY TRACT INFECTION 45 0.0003
100 DRUG INTOLERANCE 25 0.0003
101 PROCEDURAL PAIN 7 0.0003
102 PELVIC PAIN 4 0.0002
103 UROSEPSIS 2 0.0002
104 UMBILICAL HERNIA 1 0.0002
105 BLOOD URINE PRESENT 4 0.0002
106 VULVOVAGINAL PAIN 1 0.0002
107 KLEBSIELLA INFECTION 1 0.0002
108 PRODUCT USE COMPLAINT 3 0.0002
109 HIP SURGERY 1 0.0002
110 PROSTATIC DISORDER 1 0.0002
111 DISCOMFORT 11 0.0002
112 URINARY RETENTION 6 0.0002
113 NECROSIS 1 0.0002
114 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
115 NEOPLASM 2 0.0002
116 DEVICE DIFFICULT TO USE 11 0.0002
117 ADVERSE EVENT 15 0.0002
118 DEVICE DEPLOYMENT ISSUE 2 0.0002
119 SKIN MASS 1 0.0001
120 BURNING SENSATION 10 0.0001
121 PROCEDURAL COMPLICATION 1 0.0001
122 POLYURIA 1 0.0001
123 SENSATION OF FOREIGN BODY 1 0.0001
124 ANAL INCONTINENCE 1 0.0001
125 LIP DRY 1 0.0001
126 FLANK PAIN 1 0.0001
127 SPINAL DISORDER 1 0.0001
128 DEVICE ISSUE 9 0.0001
129 DECREASED ACTIVITY 1 0.0001
130 HYPONATRAEMIA 5 0.0001
131 DEVICE USE ERROR 3 0.0001
132 POST PROCEDURAL HAEMORRHAGE 1 0.0001
133 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
134 SECRETION DISCHARGE 1 0.0001
135 ABDOMINAL PAIN LOWER 2 0.0001
136 INFLAMMATION 4 0.0001
137 ADVERSE REACTION 1 0.0001
138 ADVERSE DRUG REACTION 6 0.0001
139 PRODUCT DOSE OMISSION ISSUE 19 0.0001
140 SEPSIS 7 0.0001
141 VENTRICULAR TACHYCARDIA 1 0.0001
142 DEVICE DEFECTIVE 1 0.0001
143 DEVICE USE ISSUE 1 0.0001
144 THIRST 1 0.0001
145 BACTERIAL INFECTION 1 0.0001
146 MIDDLE INSOMNIA 1 0.0001
147 BLOOD SODIUM DECREASED 1 0.0001
148 PULMONARY FIBROSIS 1 0.0001
149 PRODUCT ADMINISTRATION ERROR 1 0.0000
150 RIB FRACTURE 1 0.0000
151 POOR QUALITY SLEEP 1 0.0000
152 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
153 APPLICATION SITE PAIN 1 0.0000
154 CHROMATURIA 1 0.0000
155 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
156 AGEUSIA 1 0.0000
157 HYPOPHAGIA 1 0.0000
158 HAEMORRHAGE 4 0.0000
159 FREQUENT BOWEL MOVEMENTS 1 0.0000
160 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
161 DIVERTICULITIS 1 0.0000
162 PAIN 22 0.0000
163 DEMENTIA 1 0.0000
164 HYPERSOMNIA 1 0.0000
165 LABORATORY TEST ABNORMAL 1 0.0000
166 IRRITABILITY 2 0.0000
167 FEELING HOT 2 0.0000
168 FEMUR FRACTURE 1 0.0000
169 CONSTIPATION 7 0.0000
170 HEAD INJURY 1 0.0000
171 CYSTITIS 1 0.0000
172 BLOOD CREATININE INCREASED 2 0.0000
173 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
174 LYMPHADENOPATHY 1 0.0000
175 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
176 MUSCLE SPASMS 5 0.0000
177 COLITIS 1 0.0000
178 THROMBOSIS 2 0.0000
179 DEVICE BREAKAGE 1 0.0000
180 DEVICE LEAKAGE 1 0.0000
181 PULMONARY OEDEMA 1 0.0000
182 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
183 THERAPY NON-RESPONDER 1 0.0000
184 SKIN IRRITATION 1 0.0000
185 COGNITIVE DISORDER 1 0.0000
186 ARRHYTHMIA 1 0.0000
187 FEELING ABNORMAL 5 0.0000
188 BRADYCARDIA 1 0.0000
189 INSOMNIA 5 0.0000
190 HAEMATOCHEZIA 1 0.0000
191 LETHARGY 1 0.0000
192 CHILLS 2 0.0000
193 SURGERY 1 0.0000
194 BLADDER CANCER 1 0.0000
195 PLEURAL EFFUSION 1 0.0000
196 DEEP VEIN THROMBOSIS 1 0.0000
197 DEHYDRATION 2 0.0000
198 NEOPLASM MALIGNANT 1 0.0000
199 PYREXIA 5 0.0000
200 SLEEP DISORDER 1 0.0000
201 DYSGEUSIA 1 0.0000
202 HOT FLUSH 1 0.0000
203 CHRONIC KIDNEY DISEASE 1 0.0000
204 ABDOMINAL PAIN 3 0.0000
205 PARAESTHESIA 2 0.0000
206 OFF LABEL USE 11 0.0000
207 CARDIAC FAILURE 1 0.0000
208 DRY MOUTH 1 0.0000
209 TREATMENT FAILURE 1 0.0000
210 ABDOMINAL DISCOMFORT 2 0.0000
211 SKIN EXFOLIATION 1 0.0000
212 CEREBROVASCULAR ACCIDENT 2 0.0000
213 TACHYCARDIA 1 0.0000
214 GASTROINTESTINAL DISORDER 1 0.0000
215 OROPHARYNGEAL PAIN 1 0.0000
216 WEIGHT DECREASED 3 0.0000
217 GAIT DISTURBANCE 2 0.0000
218 ATRIAL FIBRILLATION 1 0.0000
219 HYPOTENSION 2 0.0000
220 ILLNESS 1 0.0000
221 PLATELET COUNT DECREASED 1 0.0000
222 INFLUENZA 1 0.0000
223 INCORRECT DOSE ADMINISTERED 2 0.0000
224 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
225 BACK PAIN 2 0.0000
226 DISEASE PROGRESSION 1 0.0000
227 OEDEMA PERIPHERAL 1 0.0000
228 FATIGUE 6 0.0000
229 PRODUCT QUALITY ISSUE 1 0.0000
230 ANXIETY 2 0.0000
231 INFECTION 1 0.0000
232 DIZZINESS 3 0.0000
233 FALL 2 0.0000
234 MYOCARDIAL INFARCTION 1 0.0000
235 CHEST PAIN 1 0.0000
236 PRODUCT USE ISSUE 1 0.0000
237 BLOOD GLUCOSE INCREASED 1 0.0000
238 ALOPECIA 1 0.0000
239 ERYTHEMA 1 0.0000
240 ARTHRALGIA 2 0.0000
241 HYPERTENSION 1 0.0000
242 VOMITING 2 0.0000
243 DIARRHOEA 2 0.0000
244 PNEUMONIA 1 0.0000
245 NAUSEA 2 0.0000
246 DEATH 2 0.0000
247 MALAISE 1 0.0000
248 HEADACHE 1 0.0000